Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00679419
NCT00679419
Unknown
Not Applicable

Coronary Artery Disease and Renal Failure Registry

Institut für Klinisch-Kardiovaskuläre Forschung GmbH32 sites in 1 country3,352 target enrollmentDecember 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCoronary Artery DiseaseRenal Failure

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Institut für Klinisch-Kardiovaskuläre Forschung GmbH
Enrollment
3352
Locations
32
Primary Endpoint
all cause mortality
Last Updated
13 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

It is the aim of the multi-centric and prospective registry to analyze in patients with CAD the impact of different grades of renal failure on the outcome and course of the patients and to correlate these with clinical variables.

In particular, the registry has the following objectives:

  • prospective consecutive assessment of all patients with coronary artery disease and renal failure in the participating hospitals of the registry
  • evaluation of the outcome and course of patients with regard to their different stages of renal failure at baseline
  • analysis of the impact of different therapeutic strategies on acute and long-term outcomes
  • identification of clinical risk factors, novel biomarkers and genetic markers for an unfavorable long-term outcome
Registry
clinicaltrials.gov
Start Date
December 2007
End Date
May 2013
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Institut für Klinisch-Kardiovaskuläre Forschung GmbH

Eligibility Criteria

Inclusion Criteria

  • •Women and men \>= 18 years of age
  • •Patients with actually performed interventional coronary angiography and there a documented coronary heart disease, defined as at least one documented stenosis \>= 50 % in at least one main coronary vessel (Main steam; RCX; RIVA; RCA)
  • •European/Caucasian descent (European/Caucasian parents and grandparents)
  • •Availability of an urine, serum- and EDTA blood sample of the patient
  • •Documented consent of patients for handling of personal medical data, including a genetic analysis

Exclusion Criteria

  • •Patients who have been already recruited into this registry
  • •Patients with organ transplantations, apart from kidney transplantations
  • •Immunosuppressive therapy, apart from immunosuppressive therapy after kidney transplantation
  • •Patients with polycystic renal disease
  • •Pregnant and breastfeeding patients
  • •Known malignant tumor

Outcomes

Primary Outcomes

all cause mortality

Time Frame: two years

Secondary Outcomes

  • manner of death(two years)

Study Sites (32)

Loading locations...

Similar Trials

Recruiting
Not Applicable
Prospective Registry of the Current Status of Care for Patients With Coronary Artery DiseaseCoronary Artery Disease
NCT05337319Beijing Anzhen Hospital100,000
Active, not recruiting
Not Applicable
Chronic Kidney Disease Registry Platform StudyChronic Kidney Diseases
NCT06117852AstraZeneca1,927
Completed
Not Applicable
CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial InfarctionLong-term Major Cardiovascular EventsMyocardial InfarctionPercutaneous Coronary Intervention
NCT02385682Kiyuk Chang4,748
Unknown
Not Applicable
Japan Unprotected Left Main Coronary Artery Disease Percutaneous Coronary Intervention (PCI) Strategy On New Generation StentsCoronary Artery Disease
NCT01256723Associations for Establishment of Evidence in Interventions441
Completed
Not Applicable
VASCADE ANTEGRADE-PVD Post-Market RegistrySurgical Wound
NCT02948257Cardiva Medical, Inc.52